Variava

Company Description

To help our customers deal with the changing business environment we plan on staying as their best choice for Cephalosporines. We came up with best in class Cephalosporines in many forms including Cephalosporines. We have handed over technologically advanced equipment to first in class technical engineers leading to high functioning and durable production. With quality and unbeatable functionality our product line generates Approx 5 Million US Dollar worth of annual profit, owing to Australia,Canada,Germany,South Korea,Poland of export market share and export value ranging around US$2.5 Million - US$5 Million. Variava Private Limited is operating under Agency, first introduced with US$5 Million - US$10 Million initial business capital in NEW DELHI, India and . Established back in 2010, we hold 10 Years of export history.